Summit Partners Makes Majority Growth Investment in LumaBridge
August 23, 2022
Summit Partners has made a majority growth equity investment in LumaBridge, an oncology-focused clinical research organization (CRO) headquartered in San Antonio, Texas. The capital will support LumaBridge’s expansion of clinical trial capabilities and enable the company to serve a larger number of emerging biopharma sponsors developing immuno-oncology therapies.
- Buyers
- Summit Partners
- Targets
- LumaBridge
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.